92 related articles for article (PubMed ID: 20455440)
1. Inhibitors of Epstein-Barr virus reproduction--ribonucleosides of 3-substituted 1,2,4-triazino[5,6-b] [1,4] benzothiasines.
Golovan AJ; Nesterova NV; Zagorodnya SD; Alexeeva LV; Palchykovska LI; Usenko LS; Baranova GV
Mikrobiol Z; 2010; 72(2):36-42. PubMed ID: 20455440
[TBL] [Abstract][Full Text] [Related]
2. [Effect of isonicotinic acid derivates on reproduction of Epstein-Barr virus].
Zahorodnia SD; Nesterova NV; Danylenko VP; Bukhtiarova TA; Baranova HV; Holovan' AV
Mikrobiol Z; 2011; 73(2):65-72. PubMed ID: 21598662
[TBL] [Abstract][Full Text] [Related]
3. [Effect of proteflazid on the Epschtein-Barr virus].
Zagorodniaia SD; Golovan' AV; Baranova GV; Nesterova NV
Mikrobiol Z; 2009; 71(1):57-61. PubMed ID: 19663329
[TBL] [Abstract][Full Text] [Related]
4. Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression.
Ballout M; Germi R; Fafi-Kremer S; Guimet J; Barguès G; Seigneurin JM; Morand P
J Virol Methods; 2007 Jul; 143(1):38-44. PubMed ID: 17368820
[TBL] [Abstract][Full Text] [Related]
5. Aspirin induces lytic cytotoxicity in Epstein-Barr virus-positive cells.
Liu SF; Wang H; Li ZJ; Deng XY; Xiang H; Tao YG; Li W; Tang M; Cao Y
Eur J Pharmacol; 2008 Jul; 589(1-3):8-13. PubMed ID: 18571159
[TBL] [Abstract][Full Text] [Related]
6. (Z)- and (E)-2-(hydroxymethylcyclopropylidene)-methylpurines and pyrimidines as antiviral agents.
Qiu YL; Ptak RG; Breitenbach JM; Lin JS; Cheng YC; Kern ER; Drach JC; Zemlicka J
Antivir Chem Chemother; 1998 Jul; 9(4):341-52. PubMed ID: 9875413
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility in vitro of Epstein-Barr Virus to myristoylated-peptide.
Ourth DD
Peptides; 2010 Jul; 31(7):1409-11. PubMed ID: 20362634
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infections: prospects for treatment.
Gershburg E; Pagano JS
J Antimicrob Chemother; 2005 Aug; 56(2):277-81. PubMed ID: 16006448
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB inhibitors induce lytic cytotoxicity in Epstein-Barr virus-positive nasopharyngeal carcinoma cells.
Liu SF; Wang H; Lin XC; Xiang H; Deng XY; Li W; Tang M; Cao Y
Cell Biol Int; 2008 Aug; 32(8):1006-13. PubMed ID: 18579417
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone.
Souza TM; De Souza MC; Ferreira VF; Canuto CV; Marques IP; Fontes CF; Frugulhetti IC
Antiviral Res; 2008 Jan; 77(1):20-7. PubMed ID: 17931712
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of L-dioxolane uracil nucleosides as anti-Epstein Barr virus agents.
Lin JS; Kira T; Gullen E; Choi Y; Qu F; Chu CK; Cheng YC
J Med Chem; 1999 Jun; 42(12):2212-7. PubMed ID: 10377226
[TBL] [Abstract][Full Text] [Related]
12. Xiao chai hu tang inhibits CVB1 virus infection of CCFS-1 cells through the induction of Type I interferon expression.
Cheng PW; Ng LT; Lin CC
Int Immunopharmacol; 2006 Jun; 6(6):1003-12. PubMed ID: 16644487
[TBL] [Abstract][Full Text] [Related]
13. [Ribonucleoside and 2'-deoxyribonucleoside 5'-phosphonates: synthesis and antiviral activity].
Shirokova EA; Ias'ko MV; Shipitsyn AV; Kraevskiĭ AA; Ostrander M; O'Hara B; Baron P; Maclow K; Polsky B
Mol Biol (Mosk); 1994; 28(1):224-32. PubMed ID: 8145753
[TBL] [Abstract][Full Text] [Related]
14. Bupleurum kaoi inhibits Coxsackie B virus type 1 infection of CCFS-1 cells by induction of type I interferons expression.
Cheng PW; Chiang LC; Yen MH; Lin CC
Food Chem Toxicol; 2007 Jan; 45(1):24-31. PubMed ID: 17052829
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral evaluation of isatin ribonucleosides.
de Oliveira MR; Torres JC; Garden SJ; dos Santos CV; Alves TR; Pinto AC; Pereira Hde S; Ferreira LR; Moussatché N; Frugulhetti IC; Ferreira VF; de Souza MC
Nucleosides Nucleotides Nucleic Acids; 2002; 21(11-12):825-35. PubMed ID: 12537024
[TBL] [Abstract][Full Text] [Related]
16. [AntiEBV activity of 6-azacytidine and its derivatives].
Zagorodniaia SD; Nesterova NV; Golovan' AV; Alekseeva IV; Palchikovs'kaia LI; Baranova GV
Mikrobiol Z; 2011; 73(6):41-9. PubMed ID: 22308751
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene.
Larrat S; Morand P; Bas A; Vigne S; Crance JM; Boyer V; Nicod S; Grossi L; Buisson M; Burmeister WP; Seigneurin JM; Germi R
Antivir Ther; 2009; 14(5):655-62. PubMed ID: 19704168
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication.
Meerbach A; Holý A; Wutzler P; De Clercq E; Neyts J
Antivir Chem Chemother; 1998 May; 9(3):275-82. PubMed ID: 9875407
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole.
Zacny VL; Gershburg E; Davis MG; Biron KK; Pagano JS
J Virol; 1999 Sep; 73(9):7271-7. PubMed ID: 10438815
[TBL] [Abstract][Full Text] [Related]
20. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N
Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
